title: Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.
abstract: High level microsatellite instability (MSI-H) is a hallmark of Lynch syndrome-associated colorectal cancer (CRC). MSI-H CRC express immunogenic tumour antigens as a consequence of DNA mismatch repair deficiency-induced frameshift mutations. Consequently, frameshift antigen-specific immune responses are commonly observed in patients with Lynch syndrome-associated MSI-H CRC. Dendritic cells (DC) and macrophages play a crucial role in the induction and modulation of immune responses. We here analysed DC and macrophage infiltration in MSI-H and microsatellite-stable CRC. Sixty-nine CRC (MSI-H, n = 33; microsatellite-stable, n = 36) were examined for the density of tumour-infiltrating DC, Foxp3-positive regulatory T cells, and CD163-positive macrophages. In MSI-H lesions, S100-positive and CD163-positive cell counts were significantly higher compared to microsatellite-stable lesions (S100: epithelium P = 0.018, stroma P = 0.042; CD163: epithelium P < 0.001, stroma P = 0.046). Additionally, numbers of CD208-positive mature DC were significantly elevated in the epithelial compartment of MSI-H CRC (P = 0.027). High numbers of tumour-infiltrating Foxp3-positive T cells were detected in tumours showing a low proportion of CD208-positive, mature DC among the total number of S100-positive cells. Our study demonstrates that infiltration with DC, mature DC, and macrophages is elevated in MSI-H compared to microsatellite-stable CRC. The positive correlation of Foxp3-positive Treg cell density with a low proportion of mature DC suggests that impaired DC maturation may contribute to local immune evasion in CRC. Our results demonstrate that DC and macrophages in the tumour environment likely play an important role in the induction of antigen-specific immune responses in Lynch syndrome. Moreover, impaired DC maturation might contribute to local immune evasion in CRC.
authors: Department of Applied Tumour Biology, Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 220, 69120, Heidelberg, Germany. kathrin.bauer@med.uni-heidelberg.de
authors: Kathrin
authors: K
authors: Bauer
authors: Sara
authors: S
authors: Michel
authors: Miriam
authors: M
authors: Reuschenbach
authors: Nina
authors: N
authors: Nelius
authors: Magnus
authors: M
authors: von Knebel Doeberitz
authors: Matthias
authors: M
authors: Kloor
references: Br J Cancer. 2005 May 9;92(9):1746-53
references: 15856045
references: Gastroenterology. 2008 Apr;134(4):988-97
references: 18395080
references: J Immunol. 2008 Aug 1;181(3):2220-6
references: 18641362
references: Trends Immunol. 2002 Sep;23(9):445-9
references: 12200066
references: Am J Clin Pathol. 1986 Feb;85(2):160-8
references: 2418676
references: Br J Cancer. 2008 Dec 2;99(11):1867-73
references: 18985040
references: Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6666-72
references: 18006767
references: J Transl Med. 2006 Dec 13;4:52
references: 17166272
references: Nat Immunol. 2009 Jul;10(7):689-95
references: 19536194
references: Cancer. 2001 Jun 15;91(12):2417-22
references: 11413533
references: Cancer Res. 1998 Nov 15;58(22):5248-57
references: 9823339
references: Trends Immunol. 2005 Mar;26(3):123-9
references: 15745853
references: N Engl J Med. 2003 Mar 6;348(10):919-32
references: 12621137
references: Mol Biol Cell. 2010 Aug 1;21(15):2598-610
references: 20519440
references: Nat Rev Immunol. 2010 Aug;10(8):554-67
references: 20616810
references: J Clin Oncol. 2005 Jan 20;23(3):609-18
references: 15659508
references: Int J Cancer. 2001 Jul 1;93(1):6-11
references: 11391614
references: Semin Immunol. 2004 Apr;16(2):99-106
references: 15036233
references: J Immunol. 1998 Aug 15;161(4):1883-90
references: 9712057
references: Science. 1993 May 7;260(5109):816-9
references: 8484122
references: Cancer Immunol Immunother. 2007 Dec;56(12):1993-2001
references: 17579859
references: Clin Cancer Res. 2005 Apr 1;11(7):2576-82
references: 15814636
references: Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13255-60
references: 11687624
references: Fam Cancer. 2010 Jun;9(2):173-9
references: 19957108
references: Br J Surg. 2004 Apr;91(4):469-75
references: 15048750
references: Cancer. 1989 Feb 1;63(3):496-503
references: 2912528
references: J Biochem. 2010 Jun;147(6):781-92
references: 20410014
references: Cancer Immunol Immunother. 2004 Nov;53(11):978-86
references: 15197496
references: Pathol Res Pract. 2010 Sep 15;206(9):602-6
references: 20547010
references: Eur J Immunol. 2010 Apr;40(4):1022-35
references: 20101618
references: Cancer Res. 2005 Sep 15;65(18):8072-8
references: 16166278
references: Annu Rev Immunol. 2009;27:451-83
references: 19105661
references: Hum Immunol. 2009 May;70(5):325-30
references: 19236898
references: Gastroenterology. 2007 Jul;133(1):48-56
references: 17631130
references: Clin Cancer Res. 2006 May 15;12(10):3064-9
references: 16707603
references: J Transl Med. 2007 Nov 29;5:62
references: 18047662
references: Oncology. 2005;68(2-3):276-84
references: 16015045
references: Cancer Immunol Immunother. 2010 May;59(5):653-61
references: 19908042
references: Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;61(6):409-14
references: 1349780
references: Annu Rev Immunol. 2000;18:767-811
references: 10837075
references: Am J Pathol. 1999 Jun;154(6):1805-13
references: 10362805
references: Immunity. 1998 Sep;9(3):325-36
references: 9768752
references: Nature. 1993 Jun 10;363(6429):558-61
references: 8505985
references: Int J Cancer. 2010 Sep 1;127(5):1001-10
references: 20198617
references: Blood. 1997 Nov 1;90(9):3245-87
references: 9345009
references: Immunol Lett. 2004 Jun 15;94(1-2):11-26
references: 15234530